| Filed On | Filing |
|---|---|
| 16 Nov 2026 | Form 4 |
| 16 Nov 2026 | 6-K |
| 16 Nov 2026 | SCHEDULE 13G/A |
| 13 Nov 2026 |
Form 4: O'Grady Brendan P., Director
Granted 210,000 Share options (right to buy) |
| 19 Oct 2026 | S-8 |
| 08 Oct 2026 | 6-K |
| 23 Sep 2026 | Form 3: Elmaliah Oren, Interim CFO |
| 21 Sep 2026 | Form 4: Rubin Eyal, Chief Financial Officer |
| 18 Sep 2026 | 424B5 |
| 18 Sep 2026 | 6-K |
| 14 Sep 2026 | 6-K |
| 11 Sep 2026 | EFFECT |
| 04 Sep 2026 | 6-K |
| 01 Sep 2026 | F-3 |
| 20 Aug 2026 | EFFECT |
| 19 Aug 2026 | 6-K |
| 19 Aug 2026 | POS AM |
| 17 Aug 2026 | 6-K |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 31 Jul 2026 |
Form 3: O'Grady Brendan P., Director
No securities owned |
Loading...